The University of Milan, known colloquially as UniMi or Statale, is a public research university in Milan, Italy. It is one of the largest universities in Europe, with about 60,000 students, and a permanent teaching and research staff of about 2,000.

During the past decade, University of Milan conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 9 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 4 clinical trials were completed. i.e. 44.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Milan" #1 sponsor was "University of Milan" with 8 trials, followed by "Institut Straumann AG" with 2 trials sponsored, "Ipsen" with 2 trials sponsored, "National Cancer Institute (NCI)" with 2 trials sponsored and "Novartis Gene Therapies" with 2 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Milan" #1 collaborator was "University of Milan" with 6 trials as a collaborator, "AIXIAL Development" with 1 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Asociacion Colaboracion Cochrane Iberoamericana" with 1 trials as a collaborator and "Clinica Universidad de Navarra, Universidad de Navarra" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "University of Milan" are "Acromegaly" (2 trials), "Distal Myopathy With Rimmed Vacuoles" (2 trials), "Distal Myopathy, Nonaka Type" (2 trials), "GNE Myopathy" (2 trials) and "Healthy" (2 trials). Many other conditions were trialed in "University of Milan" in a lesser frequency.

Most popular intervention types in "University of Milan" are "Drug" (15 trials), "Other" (10 trials), "Procedure" (7 trials), "Device" (6 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Onasemnogene Abeparvovec-xioi" (2 trials), "Aceneuramic Acid Extended-Release Tablets" (1 trials), "Balanced gluten free diet" (1 trials) and "Balanced low FODMAPs /gluten free diet" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Milan" are 45 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University of Milan". 2 are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in University of Milan, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in University of Milan, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 17 trials that are defined as “Not Applicable".

University of Milan has several departments that took part in Clinical trials: "UOC Maxillofacial Surgery and Odontology, University of Milan" - 5 trials, "UNIMI, Istituto Ortopedico Getano Pini" - 2 trials, "Department of Biomedical Science for Health" - 2 trials, "Respiratory Medicine Section, Dipartimento Toraco-Polmonare e Cardiocircolatorio, Università degli Studi di Milano, San Paolo Hospital" - 2 trials, "Respiratory Unit, San Paolo Hospital, Dipartimento Scienze della Salute, Università degli Studi di Milano." - 2 trials, "Arrhytmias and Heart failure Unit-Spedali Civili Hospital" - 2 trials